T44.5 Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists

Non-Billable/Non-Specific

Type 1 Excludes

poisoning by, adverse effect of and underdosing of beta-adrenoreceptor agonists used in asthma therapy (T48.6-)

Codes

T44.5XPoisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists
- T44.5X1Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional)
  T44.5X1A..., initial encounter
  T44.5X1D..., subsequent encounter
  T44.5X1S..., sequela
- T44.5X2Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm
  T44.5X2A..., initial encounter
  T44.5X2D..., subsequent encounter
  T44.5X2S..., sequela
- T44.5X3Poisoning by predominantly beta-adrenoreceptor agonists, assault
  T44.5X3A..., initial encounter
  T44.5X3D..., subsequent encounter
  T44.5X3S..., sequela
- T44.5X4Poisoning by predominantly beta-adrenoreceptor agonists, undetermined
  T44.5X4A..., initial encounter
  T44.5X4D..., subsequent encounter
  T44.5X4S..., sequela
- T44.5X5Adverse effect of predominantly beta-adrenoreceptor agonists
  T44.5X5A..., initial encounter
  T44.5X5D..., subsequent encounter
  T44.5X5S..., sequela
- T44.5X6Underdosing of predominantly beta-adrenoreceptor agonists
  T44.5X6A..., initial encounter
  T44.5X6D..., subsequent encounter
  T44.5X6S..., sequela